Background. Primary hyperaldosteronism is most commonly due to a solitary cortical adenoma. Thus, some surgeons have suggested a subtotal adrenalectomy is a reasonable approach when a mass can be identified. On the other hand, adrenal vein sampling (AVS) is being used more frequently to distinguish patients with unilateral disease for adrenalectomy, even if a discrete mass is not identified on axial imaging. In these cases, surgical pathology may reveal a cortical adenoma, a cortical adenoma with hyperplasia, or cortical hyperplasia. The goal of this study was to compare the presentation and outcome among patients undergoing adrenalectomy and found to have different histologic features. Methods. We performed a retrospective analysis of 136 patients with primary hyperaldosteronism. A total of 95 patients had an adrenalectomy for unilateral disease. The preoperative clinical and laboratory, and postoperative outcome of the three aforementioned histologic groups were compared. Results. A total of 95 patients underwent an adrenalectomy. We found no significant difference in age, gender, body mass index, duration of hypertension, number of antihypertensive medications, serum aldosterone level, serum renin level, or adrenal vein sampling ratios among the three histologic categories. We also found no significant difference among the three categories in postoperative cure rate. Conclusion. The rate of unilateral hyperplasia in patients with primary hyperaldosteronism (16 %) is likely higher than previously reported, which may be due to the increasing use of AVS. The clinical presentation and outcome of patients regardless of the histologic findings are similar. Our data also suggests that subtotal adrenalectomy would not be appropriate in patients with primary hyperaldosteronism.
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Keywords Primary hyperaldosteronism Á Adrenal vein sampling Á Aldosterone producing adenoma Primary hyperaldosteronism was first described by Conn and Louis as the association of an adrenal cortical adenoma with hypertension, hypokalemia, and excessive urinary excretion of aldosterone. 1 Increased screening of hypertensive populations has identified primary hyperaldosteronism as the leading cause of secondary hypertension, with prevalence rates as high as 18 % in patients with hypertension. 2, 3 If untreated, patients with primary hyperaldosteronism are at a greater risk for end organ damage resulting in heart and kidney dysfunction and for vascular disease than those with hypertension attributed to other causes. 2, [4] [5] [6] Once a diagnosis of primary hyperaldosteronism has been established, it is important to distinguish unilateral from bilateral adrenal disease. Unilateral disease has historically been synonymous with an aldosterone-producing adenoma and may be treated surgically. 7 On the other hand, bilateral adrenal disease is most consistent with the diagnosis of idiopathic hyperplasia and is treated with mineralocorticoid receptor antagonists. 7 Adrenal venous sampling (AVS) was first introduced in the 1960s to assist in the localization of unilateral adenoma, as the majority of aldosterone-producing adenomas (APAs) are less than 15 mm. 8 This technique was soon replaced by computed tomography (CT) scan as imaging resolution improved. 9 However, recent publications have highlighted the inaccuracy of CT scan, citing that up to 68 % of patients would have been inappropriately managed without AVS, thus advocating for use of AVS as a gold standard test before offering patients adrenalectomy. [10] [11] [12] Even with improved diagnostic efforts, untreated postoperative normotension is only achieved in 42 % of operative candidates, but most studies observe greater than 90 % of their surgical cohort have improved blood pressure on a reduced number of antihypertensive medications. [13] [14] [15] [16] [17] [18] [19] Several preoperative indicators have been associated with improved outcomes (blood pressure control), including age B 40, female gender, body mass index (BMI) B 25, duration of hypertension \ 6 years, and the need for B2 antihypertensive medications. 18 There is limited data on whether the cause of unilateral primary hyperaldosteronism (adrenal histologic features showing unilateral hyperplasia and/or cortical adenoma) is associated with a different presentation and outcome in patients undergoing adrenalectomy. 20 Thus, the goal of this study was to determine the prevalence of unilateral adrenal histologic findings and any association with presentation and outcome in patients undergoing unilateral adrenalectomy.
MATERIALS AND METHODS

Patients
A total of 136 patients with primary aldosteronism were identified who were enrolled in prospective clinical protocols approved by the Office of Human Subject Research at the National Institutes of Health (NIH) Clinical Center. Medical records were retrospectively reviewed for all patients who met criteria for surgical intervention and underwent unilateral adrenalectomy. In order to meet surgical criteria at the NIH, a patient must have: (1) biochemical testing consistent with primary hyperaldosteronism (elevated serum aldosterone level with suppressed plasma renin and elevated aldosterone-to-renin ratio [20) , (2) secondary confirmation of the diagnosis with sodium chloride loading test, a captopril test, or a posture test, and (3) unilateral disease by AVS in all patients. No cosecretors were included. Patient demographics, clinical information, preoperative, and postoperative data was collected.
Adrenal Venous Sampling
Adrenal venous sampling was performed in all patients with primary hyperaldosteronism, as previously described, regardless of CT scan findings. 9 Bilateral adrenal veins were simultaneously catheterized through access of the ipsilateral femoral veins. For right adrenal vein sampling, either a 4 French Mickaelsson, a Simmons 1, or a Cobra 2 catheter was used. For left adrenal vein sampling, a 4 French Simmons 2 or 3 catheter or a sub-3 French microcatheter was used. Samples from the right iliac vein were used as the peripheral venous samples to compare adrenal vein levels for cortisol and aldosterone. For all time points, a blood sample was collected from each adrenal vein and the right iliac vein. There were two baseline levels drawn prior to an intravenous bolus of 0.25 mg of adrenocorticotropin hormone (ACTH). An ACTH infusion was then started (0.25 mg in 250 mL normal saline) at 150 mL/hour. Additional samples were drawn at 5, 10, and 15 minutes after infusion of ACTH.
An aldosterone-to-cortisol (AC) ratio was calculated for each sample. If the AC ratio was at least 4 times greater on one side compared with both contralateral adrenal and peripheral ratios, a diagnosis of unilateral hyperfunctioning adrenal gland was made and the patient was offered an adrenalectomy.
Histopathologic Classification
Surgical pathology reports were reviewed to categorize patients by histopathologic diagnosis. Available tissue sections of unilateral hyperplasia were additionally reviewed by a pathologist at the NIH for confirmation of the histologic diagnosis. At our institution, adrenocortical hyperplasia is defined as an increase in the number of adrenocortical cells above the expected component of the zona glomerulosa (expected 5-10 % of total cortex) without the presence of a cortical adenoma and the uninvolved adrenal tissues not being atrophied.
Outcomes
Clinical outcome by different histopathologic diagnosis was measured by change in number of antihypertensive medications as well as change in mean arterial pressure (MAP) both at time of discharge (postoperative value).
Statistical Methods
Statistical significance was defined as p B .05. Intragroup associations were analyzed using the Wilcoxon signed-rank test. The Kruskal-Wallis test was used to determine intergroup associations. Cure rates among groups were compared using a 3 9 2 Fisher exact test. Wilcoxon signed-rank tests and Kruskal-Wallis tests were performed using StatView software (SAS Institute, Inc., Cary, NC, USA). Fisher exact test was performed using In-Silico Fisher exact test (http://in-silico. net/statistics/fisher_exact_test/2x3, Fairbanks, AK, USA).
RESULTS
Of the 136 patients, 95 underwent surgical intervention for unilateral primary hyperaldosteronism with histologic examination. Of these, 66 patients had an aldosterone-producing cortical adenoma, and 14 patients demonstrated an aldosterone-producing adenoma with diffuse adrenal hyperplasia. Histopathology of the remaining 15 patients showed diffuse cortical hyperplasia without evidence of a cortical adenoma (Fig. 1) . For these 15 patients, the diagnosis manifested as multinodular hyperplasia in 10 patients and nonnodular hyperplasia in 5 patients. There was no significant difference between these groups in terms of age at diagnosis, gender distribution, BMI, duration of hypertension, number of preoperative antihypertensive medications, or preoperative aldosterone or renin level. Additionally, there was no significant difference in the clinical and laboratory features associated with patient outcome by histologic groups (Table 1) . Patients' clinical outcomes were followed for a median of 3 months, with a range of 0.1-87 months.
All 3 histologic categories showed significant postsurgical improvement in the number of antihypertensive medications required to control blood pressure at discharge (p \ .05, Table 2 ). Additionally, all 3 histologic categories showed significant improvement in MAP at the time of discharge (p \ .05, Table 3 ).
DISCUSSION
Our results suggest that the clinical presentation and outcome of patients with unilateral primary hyperaldosteronism are similar regardless of the histopathologic diagnosis. A solitary cortical adenoma, previously believed to account for the vast majority of histologic diagnoses of surgical primary hyperaldosteronism, was not as prevalent in our series. This is likely due to the use of AVS, rather than radiography, for evidence of unilateral disease. Furthermore, all 3 histologic categories demonstrated similar postoperative cure rates and similar quantitative improvements in number of antihypertensive medications and MAP.
Of the 95 patients in our cohort treated for unilateral primary hyperaldosteronism, 69 % were due to a solitary cortical adenoma, 15 % were due to cortical adenoma with cortical hyperplasia, and 16 % were due to cortical hyperplasia. Unilateral adrenal hyperplasia has been described as a rare disease throughout the literature; however, the frequency is rarely cited. Since Ross published the initial description of unilateral cortical hyperplasia, the majority of publications addressing unilateral adrenal hyperplasia were single-case reports or small case series, with fewer than 30 cases described by 2005.
12,21-41 A prospective study in Japan is the only large-scale population-based trial we were able to identify that attempted to describe the prevalence of unilateral adrenal hyperplasia, finding this disease process in 0.1 % of 1,020 hypertensive patients. 42 Based on this, it has been estimated that unilateral adrenal hyperplasia accounts for less than 1 % of all patients with primary hyperaldosteronism. 39 Since 2005, we identified six studies that assess patient outcomes based on histopathologic diagnosis of unilateral primary hyperaldosteronism. Unilateral adrenal hyperplasia accounted for 10-36 % of the cohort in these series. 7, 20, [43] [44] [45] [46] In 4 of these studies, the diagnosis of In the setting of aldosterone excess, the most common findings are hyperplasia of the zona glomerulosa (see arrows) and micronodules unilateral adrenal hyperplasia was based exclusively on CT scan or CT scan in combination with other methods for lateralization technique, a tool that has since been described as inaccurate for this purpose. 9, 11, 12 Murashima and colleagues used AVS exclusively in their series of 52 patients, while Quillo and colleagues used AVS for all patients except women younger than 40 years of age with a clearly identifiable adrenal mass on imaging. The incidences of unilateral adrenal hyperplasia in these studies were 17 and 14 %, respectively, which is similar to our finding of a 16 % rate of unilateral adrenal hyperplasia. 20, 43 The prevalence of cortical adenoma within cortical hyperplasia is poorly described in the literature. Murashima and colleagues identified an adenoma within hyperplasia in 3 of 52 patients (6 %), while Proye and colleagues identified this diagnosis in 24 of 100 (24 %). 43, 45 Our analysis identified a prevalence of 15 %.
All histologic categories in our cohort achieved statistically significant improvement in the number of required postoperative antihypertensive medications as well as postoperative MAP. Several investigators have observed clinical improvement in patients who had a histologic diagnosis Renin, ng/dL ± SD 0.9 ± 2.9 0.7 ± 0.4 0.6 ± 0.2 0.8 ± 2.4 .33 
Adenoma and hyperplasia (n = 14) 3.2 ± 1.4 (n = 14) 2.0 ± 1.8 (n = 10) .0277
Data are presented as mean ± SD Total (n = 95) 113.1 ± 14.7 (n = 94) 103.4 ± 11.4 (n = 82) \.0001
Data are presented as mean ± standard deviation consistent with a solitary cortical adenoma. 7, 44, 46 However, in studies in which AVS was used to select patients for adrenalectomy, no significant difference in outcome, based on histologic diagnosis, was observed. 20, 43, 45 In conclusion, as AVS is becoming widely used to select patients with primary hyperaldosteronism for adrenalectomy, there is a higher likelihood that these patients will have histologic findings showing higher rates of nonsolitary cortical adenoma. We observed 16 % of patients with primary hyperaldosteronism had unilateral adrenal cortical hyperplasia without cortical adenoma. The clinical presentation and outcome of patients regardless of the histologic findings are similar. As such, subtotal adrenalectomy may not be appropriate in patients with primary hyperaldosteronism, since cortical hyperplasia may account for increased hormone production in patients with cortical adenoma.
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